Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lithium
Drug ID BADD_D01302
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code N05AN01
DrugBank ID Not Available
KEGG ID D08133
MeSH ID D008094
PubChem ID 3028194
TTD Drug ID D5MF8Y
NDC Product Code Not Available
UNII 9FN79X2M3F
Synonyms Lithium | Lithium-7 | Lithium 7
Chemical Information
Molecular Formula Li
CAS Registry Number 7439-93-2
SMILES [Li]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Headache17.14.01.001--
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hyperreflexia17.02.01.002--Not Available
Hypotension24.06.03.002--
Hypothyroidism14.11.01.012; 05.02.03.001--
Joint swelling15.01.02.004--Not Available
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
Leukocytosis01.02.01.002--
Loss of consciousness17.02.04.004--Not Available
Muscular weakness15.05.06.001; 17.05.03.005--
Nausea07.01.07.001--
Nystagmus17.02.02.006; 06.05.02.006--
Oliguria20.01.03.004--Not Available
Peripheral circulatory failure24.06.02.020--Not Available
Polyuria20.02.03.002--Not Available
Pruritus23.03.12.001--
Psoriasis23.03.14.002; 10.02.01.036--Not Available
Psychomotor retardation19.15.02.002--Not Available
Rash23.03.13.001--Not Available
Restlessness17.02.05.021; 19.11.02.002--
Seizure17.12.03.001--
Skin ulcer24.04.03.007; 23.07.03.003--
Somnolence19.02.05.003; 17.02.04.006--
Stupor17.02.04.007; 19.02.05.004--Not Available
Thirst14.03.02.007; 08.01.09.021--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Tremor17.01.06.002--
Urinary incontinence20.02.02.010; 17.05.01.008--
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred17.17.01.010; 06.02.06.007--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene